Sivik Global Healthcare LLC Acquires 1,000 Shares of Waters Corporation $WAT

Sivik Global Healthcare LLC boosted its holdings in shares of Waters Corporation (NYSE:WAT) by 5.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 18,000 shares of the medical instruments supplier’s stock after purchasing an additional 1,000 shares during the quarter. Waters comprises 1.7% of Sivik Global Healthcare LLC’s portfolio, making the stock its 16th biggest holding. Sivik Global Healthcare LLC’s holdings in Waters were worth $6,283,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in WAT. OVERSEA CHINESE BANKING Corp Ltd raised its stake in Waters by 676.8% during the 1st quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 705,733 shares of the medical instruments supplier’s stock valued at $260,112,000 after purchasing an additional 614,877 shares during the period. Alliancebernstein L.P. raised its stake in Waters by 15.7% during the 1st quarter. Alliancebernstein L.P. now owns 3,070,671 shares of the medical instruments supplier’s stock valued at $1,131,757,000 after purchasing an additional 416,669 shares during the period. Wellington Management Group LLP raised its stake in Waters by 93.3% during the 1st quarter. Wellington Management Group LLP now owns 572,823 shares of the medical instruments supplier’s stock valued at $211,125,000 after purchasing an additional 276,433 shares during the period. Nuveen LLC bought a new stake in Waters during the 1st quarter valued at approximately $94,028,000. Finally, Vanguard Group Inc. grew its holdings in Waters by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 7,272,252 shares of the medical instruments supplier’s stock valued at $2,680,334,000 after buying an additional 173,584 shares in the last quarter. Institutional investors own 94.01% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on WAT shares. JPMorgan Chase & Co. raised their price target on Waters from $300.00 to $325.00 and gave the company a “neutral” rating in a report on Thursday. Rothschild Redb upgraded Waters to a “strong-buy” rating in a report on Wednesday. Weiss Ratings restated a “hold (c)” rating on shares of Waters in a report on Wednesday. Wall Street Zen cut Waters from a “buy” rating to a “hold” rating in a report on Saturday, July 26th. Finally, UBS Group restated a “neutral” rating on shares of Waters in a report on Tuesday, July 15th. Two equities research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, Waters currently has a consensus rating of “Moderate Buy” and a consensus target price of $377.56.

Waters Price Performance

Shares of Waters stock opened at $331.74 on Friday. The stock has a market cap of $19.75 billion, a price-to-earnings ratio of 29.91, a price-to-earnings-growth ratio of 3.09 and a beta of 1.04. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75. The stock has a 50 day moving average price of $299.97 and a 200-day moving average price of $323.89. Waters Corporation has a one year low of $275.05 and a one year high of $423.56.

Waters (NYSE:WAT) last announced its earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 EPS for the quarter. The firm had revenue of $608.55 million during the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%. Equities analysts expect that Waters Corporation will post 12.86 EPS for the current year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.